Martin James David Clift (Martin J D Clift)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Venues

ACS nano

Biomedicines

Journal of nanobiotechnology

Small (Weinheim an der Bergstrasse, Germany)

Swansea University Medical School

Edinburgh Napier University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Swansea University Medical School Mar 01 2019

United Kingdom

Associate Professor

Swansea University College of Medicine Mar 01 2017 - Feb 28 2019

United Kingdom

Senior Lecturer

Swansea University College of Medicine Dec 01 2015 - Mar 01 2017

United Kingdom

Lecturer :: College of Medicine

University of Fribourg Nov 01 2012 - Nov 30 2015

Switzerland

Senior Researcher (Group Leader) :: Adolphe Merkle Institute

University of Fribourg Nov 01 2011 - Oct 31 2012

Switzerland

Research Associate :: Adolphe Merkle Institute

University of Bern Nov 01 2010 - Oct 30 2011

Switzerland

Research Fellow :: Department of Clinical Research

University of Bern Sep 01 2008 - Oct 31 2010

Switzerland

Post-Doctoral Researcher :: Institute of Anatomy

Education History

Edinburgh Napier University May 01 2005 - Jul 17 2009

United Kingdom

PHD :: Life Sciences

Napier University Sep 01 2000 - Jun 01 2004

United Kingdom

BSC :: Life Sciences

Publications

Scott Brown, Stephen J Evans, Michael J Burgum, Kirsty Meldrum, Jack Herridge, Blessing Akinbola, Llinos G Harris, Rowena Jenkins, Shareen H Doak, Martin James David Clift, Thomas S Wilkinson
An In Vitro Model to Assess Early Immune Markers Following Co-Exposure of Epithelial Cells to Carbon Black (Nano)Particles in the Presence of S. aureus : A Role for Stressed Cells in Toxicological Testing. Biomedicines 12 (1) (2024)
Scott Brown, Stephen J Evans, Michael J Burgum, Kirsty Meldrum, Jack Herridge, Blessing Akinbola, Llinos G Harris, Rowena Jenkins, Shareen H Doak, Martin James David Clift, Thomas S Wilkinson
An In Vitro Model to Assess Early Immune Markers Following Co-Exposure of Epithelial Cells to Carbon Black (Nano)Particles in the Presence of S. aureus : A Role for Stressed Cells in Toxicological Testing. Biomedicines 12 (1) (2024)
Kirsty Meldrum, Joana A Moura, Shareen H Doak, Martin James David Clift
Dynamic Fluid Flow Exacerbates the (Pro-)Inflammatory Effects of Aerosolised Engineered Nanomaterials In Vitro. Nanomaterials (Basel, Switzerland) 12 (19) (2022)
Shareen H Doak, Martin James David Clift, Anna Costa, Christiaan Delmaar, Ilse Gosens, Sabina Halappanavar, Sean Kelly, Willie J G M Pejinenburg, Barbara Rothen-Rutishauser, Roel P F Schins, Vicki Stone, Lang Tran, Martina G Vijver, Ulla Vogel, Wendel Wohlleben, Flemming R Cassee
The Road to Achieving the European Commission's Chemicals Strategy for Nanomaterial Sustainability-A PATROLS Perspective on New Approach Methodologies. Small (Weinheim an der Bergstrasse, Germany) 18 (17) (2022)
Sandra Hočevar, Viola Puddinu, Laetitia Haeni, Alke Petri-Fink, Julia Wagner, Montserrat Alvarez, Martin James David Clift, Carole Bourquin
PEGylated Gold Nanoparticles Target Age-Associated B Cells In Vivo. ACS nano 16 (11) (2022)
Anthony D Horlock, Thomas J R Ormsby, Martin James David Clift, José E P Santos, John James Bromfield, Iain Martin Sheldon
Cholesterol supports bovine granulosa cell inflammatory responses to lipopolysaccharide. Reproduction (Cambridge, England) 164 (3) (2022)
Kirsty Meldrum, Stephen J Evans, Ulla Birgitte Vogel, Lang Tran, Shareen H Doak, Martin James David Clift
The influence of exposure approaches to in vitro lung epithelial barrier models to assess engineered nanomaterial hazard. Nanotoxicology 16 (1) (2022)
Michael J Burgum, Martin James David Clift, Stephen J Evans, Nicole Hondow, Afshin Tarat, Gareth J Jenkins, Shareen H Doak
Few-layer graphene induces both primary and secondary genotoxicity in epithelial barrier models in vitro. Journal of nanobiotechnology 19 (1) (2021)
James G Cronin, Nicholas Jones, Catherine A Thornton, Gareth J S Jenkins, Shareen H Doak, Martin James David Clift
Nanomaterials and Innate Immunity: A Perspective of the Current Status in Nanosafety. Chemical research in toxicology 33 (5) (2020)
Martin James David Clift, Gareth J S Jenkins, Shareen H Doak
An Alternative Perspective towards Reducing the Risk of Engineered Nanomaterials to Human Health. Small (Weinheim an der Bergstrasse, Germany) 16 (36) (2020)
Sandra Hočevar, Ana Milošević, Laura Rodriguez-Lorenzo, Liliane Ackermann-Hirschi, Inès Mottas, Alke Petri-Fink, Barbara Rothen-Rutishauser, Carole Bourquin, Martin James David Clift
Polymer-Coated Gold Nanospheres Do Not Impair the Innate Immune Function of Human B Lymphocytes in Vitro. ACS nano 13 (6) (2019)
Hana Barosova, Savvina Chortarea, Pavlína Peikertová, Martin James David Clift, Alke Petri-Fink, Jana Kukutschova, Barbara Rother-Rutishauser
Biological response of an in vitro human 3D lung cell model exposed to brake wear debris varies based on brake pad formulation. Archives of toxicology 92 (7) (2018)
Jean-Pierre Brog, Aurélien Crochet, Joël Seydoux, Martin James David Clift, Benoît Baichette, Sivarajakumar Maharajan, Hana Barosova, Pierre Brodard, Mariana Spodaryk, Andreas Züttel, Barbara Rother-Rutishauser, Nam Hee Kwon, Katharina M Fromm
Characteristics and properties of nano-LiCoO2 synthesized by pre-organized single source precursors: Li-ion diffusivity, electrochemistry and biological assessment. Journal of nanobiotechnology 15 (1) (2017)
Savvina Chortarea, Hana Barosova, Martin James David Clift, Peter Wick, Alke Petri-Fink, Barbara Rothen-Rutishauser
Human Asthmatic Bronchial Cells Are More Susceptible to Subchronic Repeated Exposures of Aerosolized Carbon Nanotubes At Occupationally Relevant Doses Than Healthy Cells. ACS nano 11 (8) (2017)

Martin James David Clift.css-eqlu8i{font-size:small;padding-left:4px;} (Martin J D Clift)

Publication Activity (10 Years)

Top Topics

Top Venues

Martin James David Clift (Martin J D Clift)